Prior to joining ABio-X, Sean was a Managing Director of CBC Group, co-founded and served as the CEO of Everest Medicines and was the VP of Global Business Development at Simcere Pharmaceutical Group. Sean was also the President and Board Director at Simcere America, a wholly owned subsidiary. Previously, Sean was the Senior Director of Alternative Partnerships, Evaluation & Expertise at Sanofi. Before Sanofi, Sean was an Associate at New Leaf Venture Partners, a healthcare VC firm. Earlier in his career, Sean worked in the pharmaceutical and diagnostic industries at Aventis and Johnson & Johnson. Sean currently serves as the Chairman of NiKang Therapeutics. He holds a PhD in Microbiology from the University of Virginia, an MBA with honor from the Wharton School of the University of Pennsylvania, and a Bachelor of Science in Microbiology from Nankai University, China.